MedPath

ong term follow-up after intrauterine transfusio

Completed
Conditions
Rhesus-baby
Severe anemia with intrauterine transfusion of the fetus
10016849
10012562
Registration Number
NL-OMON31534
Lead Sponsor
Sanquin Bloedbank
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
800
Inclusion Criteria

Mothers and their live offspring who were treated with intrauterine transfusion.

Exclusion Criteria

None

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Identify, in the heavily RBC alloimmunized population of females after HDN<br /><br>treatment whether particular MHC class II alleles are associated with presence<br /><br>or absence of particular RBC immunization.<br /><br>2. Determine the long-term neuromotor development, cognitive development and<br /><br>psychosocial well-being in a large group of children treated with IUT for fetal<br /><br>anemia. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath